Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2026-02-26 @ 2:00 AM
Study NCT ID:
NCT03074318
Status:
TERMINATED
Last Update Posted:
2022-04-29
First Post:
2017-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-01
First Submit QC Date:
None
Study First Post Date:
2017-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-10
Results First Submit QC Date:
None
Results First Post Date:
2022-04-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-27
Last Update Post Date:
2022-04-29
Last Update Post Date Type:
ACTUAL